| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net Loss | ||||||
-14,992 | -20,729 | -29,964 | -28,526 | -21,377 | -3,342 | -7,912 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation | ||||||
- | - | - | - | - | 30 | 27 |
Amortization of premium/discount on available-for-sale securities | ||||||
4 | 51 | 2 | -131 | -651 | -30 | -30 |
Gain on sale of fixed assets | ||||||
- | - | - | - | - | - | 65 |
Accretion of discount and debt issuance cost of convertible notes payable | ||||||
- | - | - | - | - | 742 | 749 |
Unrealized loss on forward foreign currency contracts included in net income | ||||||
- | - | - | 127 | -537 | 0 | 0 |
Foreign currency remeasurement (loss) | ||||||
- | 25 | 173 | -76 | -75 | 0 | 0 |
Stock based compensation | ||||||
943 | 3,429 | 3,227 | 3,343 | 2,164 | 459 | 155 |
Depreciation | ||||||
279 | 115 | 148 | 123 | 57 | - | - |
Change in fair value of investor rights/obligation | ||||||
- | - | - | - | - | 5,151 | 0 |
Change in fair value of derivative liability | ||||||
- | - | - | - | - | 81 | -2 |
Prepaid expenses and other current assets | ||||||
-608 | -141 | -297 | -246 | 899 | 961 | -72 |
Operating lease right-of-use asset | ||||||
-200 | - | - | - | - | - | - |
Interest receivable | ||||||
-17 | -49 | 46 | 26 | 32 | 0 | 0 |
Accounts payable and accrued expenses | ||||||
-2,497 | -6,162 | 4,161 | 1,073 | 1,258 | 955 | 177 |
Operating lease liability | ||||||
-200 | - | - | - | - | - | - |
Net cash used in operating activities | ||||||
-15,646 | -23,233 | -22,352 | -23,687 | -17,566 | - | - |
Accrued interest payable | ||||||
- | - | - | - | - | 115 | 112 |
Deferred revenue from sale of acquisition option to acquire company | ||||||
- | - | - | - | - | -2,948 | 0 |
Net cash used in operating activities | ||||||
- | - | - | - | - | -9,990 | -6,657 |
Purchases of available-for-sale investments | ||||||
- | 15,443 | 32,942 | 39,756 | 88,644 | 34,950 | 3,878 |
Proceeds from maturities of available-for-sale investments | ||||||
2,500 | 31,990 | 16,878 | 59,943 | 75,505 | 22,518 | 6,550 |
Proceeds from sale of available-for-sale investments | ||||||
- | 1,999 | - | - | 2,006 | 0 | 0 |
Purchase of property and equipment | ||||||
16 | 119 | 35 | 271 | 198 | 51 | 10 |
Net cash provided by/(used in) investing activities | ||||||
2,484 | 18,427 | -16,099 | 19,916 | -11,331 | - | - |
Sale of property and equipment | ||||||
- | - | - | - | - | - | 65 |
Net cash (used in) provided by investing activities | ||||||
- | - | - | - | - | -12,483 | 2,727 |
Net proceeds from IPO | ||||||
- | - | - | - | - | 62,485 | 0 |
Proceeds from issuance of convertible notes payable | ||||||
- | - | - | - | - | - | 4,339 |
Payments for debt issuance costs | ||||||
- | - | - | - | - | - | 46 |
Cash flows from financing activities: | ||||||
Proceeds from issuance of common stock, net of issuance costs | ||||||
- | 2,853 | 1,288 | - | 0 | - | - |
Proceeds from the issuance of Series A Convertible Preferred Stock, net of issuance costs | ||||||
- | - | 21,523 | - | 0 | - | - |
Proceeds from issuance of Series D preferred stock | ||||||
- | - | - | - | - | 25,000 | 0 |
Issuance costs for preferred stock | ||||||
- | - | - | - | - | 452 | 0 |
Proceeds from issuance of common stock under ESPP | ||||||
- | 132 | 130 | 11 | 75 | 0 | 0 |
Exercise of stock options | ||||||
- | - | 108 | 197 | 88 | 59 | 21 |
Net cash provided by financing activities | ||||||
- | 2,985 | 23,049 | 208 | 163 | - | - |
Effect of exchange rate changes on cash | ||||||
- | 22 | 180 | -76 | - | - | - |
Decrease in cash, cash equivalents and restricted cash | ||||||
-13,162 | -1,799 | -15,222 | -3,639 | - | - | - |
Exercise of warrants | ||||||
- | - | - | - | - | 1,428 | 0 |
Net cash provided by financing activities | ||||||
- | - | - | - | - | 88,520 | 4,314 |
Effect of exchange rate changes on cash | ||||||
- | - | - | - | -75 | 0 | 0 |
Decrease in cash and cash equivalents | ||||||
- | - | - | - | -28,809 | 66,047 | 384 |
Supplemental cash flow information | ||||||
Accretion of convertible preferred stock | ||||||
- | - | 6,747 | - | 0 | 6,353 | 6,119 |
Conversion of convertible notes, including accrued interest, into Series D Redeemable Convertible Preferred Stock | ||||||
- | - | - | - | - | 6,089 | 0 |
Fair value of derivative embedded within convertible notes payable | ||||||
- | - | - | - | - | - | 1,445 |
Conversion of redeemable convertible preferred stock into common stock | ||||||
- | - | - | - | - | 126,836 | 0 |
Fair value of investors' rights/ obligations reclassified to equity upon IPO | ||||||
- | - | - | - | - | 1,408 | 0 |